Vaxart Inc

Vaxart insider sales spike amid volatile market—Cummings’ March 28 sale signals cautious confidence, prompting investors to watch short‑term swings.

CEO Lo Steven’s bulk purchase of Vaxart shares signals long‑term confidence in the company’s oral vaccine platform, hinting at potential future upside.